Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Revvity, Inc. (RVTY) News - StockMarketCap

Stocks›Revvity, Inc.☆

● At closeAs of Jul 2, 2026

Revvity, Inc.

RVTY✓

HealthcareMedical - Diagnostics & ResearchNYSE

$113.76+0.82%

$12.69BMarket cap

52.72xP/E ratio

698.25KVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$113.76

$0.92 (+0.82%) · 24h

Key metrics

Market cap$12.69B+10.68%

Enterprise value$14.84B

Volume (24h)698.25K

P/E ratio (TTM)52.72x

P/S ratio (TTM)4.26x

Dividend yield0.25%

Shares outstanding111.56M

Trading range

Previous close$112.84

Day range$112.19 - $114.51

52-week range$81.22 - $118.30

Revvity, Inc. (RVTY) operates in the Medical - Diagnostics & Research industry within the Healthcare sector, listed on NYSE.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news